Summary of Changes

Major revision for enhanced usability including:

1. New ACLS-style STAT treatment algorithms with streamlined bedside decision-making.
2. Expanded and updated antivenom profiles, dosing guidance, and BB-IND usage instructions in addition to FDA considerations.
3. New printable rapid-reference tools to enhance usability in austere environments including Antivenom Dosing by Product and Pre-Mission AV selection flowcharts.
4. Reorganized guidelines by CCMD for faster pre-mission planning and point-of-care use, including a suggested packing checklist.
5. INDOPACOM expanded + enhanced coverage with new dedicated regional pathways for Taiwan, Japan, Korean Peninsula, China / East Asia, and elsewhere.